
This Diabetes Drug Increases the Risk of Pancreatic Cancer DocWire News
Patients with type 2 diabetes who are treated with dipeptidyl peptidase-4 (DPP-4) inhibitors are at risk for developing pancreatitis and pancreatic cancer, …
“pancreatic cancer” – Google News
